| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Revenue | $0.2B | $0.1B |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| R&D Expense | — | — |
| SG&A Expense | — | — |
| Operating Income | $0.1B | $-0.0B |
| Net Income | $0.0B | $0.0B |
| EPS (Basic) | $1.18 | $0.28 |
| EPS (Diluted) | $0.94 | $0.07 |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Total Assets | $1.4B | $1.0B |
| Current Assets | $0.1B | $0.1B |
| Cash & Equivalents | $0.0B | $0.0B |
| Total Liabilities | $0.6B | $0.4B |
| Current Liabilities | $0.0B | $0.0B |
| Stockholders' Equity | $0.3B | $0.4B |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B |
| Investing Cash Flow | $-0.2B | $-0.7B |
| Capital Expenditures | — | — |
| Financing Cash Flow | $0.1B | $0.7B |